Naglazyme (galsulfase)

pCPA File Number: 20941
Negotiation Status:
Negotiations were not pursued
Indication(s):
Mucopolysaccharidosis VI
Sponsor/Manufacturer:
BioMarin Pharmaceutical Inc.
CDA-AMC Project Number:
SR0434-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: